Biochemical Marker for Menkes Disease
Plasma and CSF levels of catechols in 10 patients with Menkes disease, ranging in age from 9 days to 27 months, were compared with control groups and patients with congenital absence of dopamine-B-hydroxylase (DBH) at the National Institutes of Health, Bethesda, MD.
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
1993-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Plasma and CSF levels of catechols in 10 patients with Menkes disease, ranging in age from 9 days to 27 months, were compared with control groups and patients with congenital absence of dopamine-B-hydroxylase (DBH) at the National Institutes of Health, Bethesda, MD. |
---|---|
Item Description: | 1043-3155 2166-6482 10.15844/pedneurbriefs-7-2-7 |